The estimated Net Worth of David C. Duffy is at least $3.21 Million dollars as of 23 March 2022. David Duffy owns over 3,266 units of Quanterix Corp stock worth over $660,591 and over the last 6 years he sold QTRX stock worth over $2,034,127. In addition, he makes $511,932 as Senior Vice President and Research & Development and Chief Technology Officer at Quanterix Corp.
Sign up
David Duffy QTRX stock SEC Form 4 insiders trading
David has made over 38 trades of the Quanterix Corp stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 3,266 units of QTRX stock worth $97,980 on 23 March 2022.
The largest trade he's ever made was exercising 41,246 units of Quanterix Corp stock on 3 January 2022 worth over $106,827. On average, David trades about 2,717 units every 30 days since 2018. As of 23 March 2022 he still owns at least 54,730 units of Quanterix Corp stock.
You can see the complete history of David Duffy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Duffy biography
Dr. David C. Duffy serves as Senior Vice President, Research & Development and Chief Technology Officer of the Company. Prior to this role, Dr. Duffy served as our Vice President, Research from November 2011 to February 2013, and Senior Director, Platform Research from July 2007 to October 2011. Prior to joining us, Dr. Duffy served as Director, Pharmacomer Technology at Surface Logix, Inc., a biomedical development company. Prior to that, Dr. Duffy was a Senior Scientist at Gamera Bioscience Corporation, a developer of automated biotechnology test equipment, from December 1998 to January 2000. Previously, Dr. Duffy was a postdoctoral research fellow in the
What is the salary of David Duffy?
As the Senior Vice President and Research & Development and Chief Technology Officer of Quanterix Corp, the total compensation of David Duffy at Quanterix Corp is $511,932. There are 5 executives at Quanterix Corp getting paid more, with E. Kevin Hrusovsky having the highest compensation of $3,631,000.
How old is David Duffy?
David Duffy is 49, he's been the Senior Vice President and Research & Development and Chief Technology Officer of Quanterix Corp since 2013. There are 16 older and 5 younger executives at Quanterix Corp. The oldest executive at Quanterix Corp is Dr. David R. Walt Ph.D., 68, who is the Co-Founder, Chairman of Scientific Advisory Board & Independent Director.
What's David Duffy's mailing address?
David's mailing address filed with the SEC is C/O QUANTERIX CORPORATION,, 900 MIDDLESEX TURNPIKE, BILLERICA, MA, 01821.
Insiders trading at Quanterix Corp
Over the last 7 years, insiders at Quanterix Corp have traded over $25,118,881 worth of Quanterix Corp stock and bought 1,481,095 units worth $18,701,541 . The most active insiders traders include David R Walt, Paul M Meister, and Keith Crandell. On average, Quanterix Corp executives and independent directors trade stock every 7 days with the average trade being worth of $100,483. The most recent stock trade was executed by Masoud Toloue on 13 August 2024, trading 19,000 units of QTRX stock currently worth $207,100.
What does Quanterix Corp do?
quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).
What does Quanterix Corp's logo look like?
Complete history of David Duffy stock trades at Quanterix Corp
Quanterix Corp executives and stock owners
Quanterix Corp executives and other stock owners filed with the SEC include:
-
E. Kevin Hrusovsky,
Chairman of the Board, President, Chief Executive Officer -
John Fry,
General Counsel, Secretary -
Amol Chaubal,
Chief Financial Officer -
E. Kevin Hrusovsky,
Chairman & CEO -
Dawn Mattoon,
Senior Vice President - Research Products -
David Duffy,
Senior Vice President, Research & Development and Chief Technology Officer -
Sarah Hlavinka,
Independent Director -
Mark Roskey,
Senior Vice President - Commercial and Accelerator -
Martin Madaus,
Lead Independent Director -
Paul Meister,
Independent Director -
Keith Crandell,
Independent Director -
Marijn Dekkers,
Independent Director -
David Walt,
Independent Director -
Dr. David R. Walt Ph.D.,
Co-Founder, Chairman of Scientific Advisory Board & Independent Director -
William Geist,
Chief Operating Officer -
Dr. Masoud Toloue Ph.D.,
Pres, CEO & Director -
Dr. Dawn R. Mattoon Ph.D.,
Sr. VP of Diagnostics -
Dr. Mark T. Roskey Ph.D.,
Sr. VP of Strategic Partnerships -
Dr. David C. Duffy Ph.D.,
Sr. VP of R&D and CTO -
Michael A. Doyle,
CFO & Treasurer -
Masoud Toloue,
Pres & Head of Diagnostics Bus. -
David Panzerella,
VP of Sales -
William Geist,
Chief Operating Officer -
Bruce J. Bal,
VP of Operations, Service & Quality -
John J. Fry,
Gen. Counsel & Corp. Sec. -
Brian J Blaser,
-
Shawn Stetson,
Interim CFO and Treasurer -
Venture Fund Vi Lparch Vent...,
-
Ventures Fund 2004 L P Flag...,
-
Capital Venture Investors, ...,
-
Ernest Orticerio,
SVP Finance and Corporate Dev -
Douglas G. Cole,
-
John M Connolly,
-
Jackson Streeter,
SVP, Corp Dev & Strategy -
Bruce J Bal,
VP of Ops, Service and Quality -
Joseph Driscoll,
Chief Financial Officer -
Amee Desjourdy,
Chief Human Resource Officer -
Laurie J Olson,
-
Michael A Doyle,
CFO and Treasurer -
Masoud Toloue,
President & CEO -
Karen Flynn,
-
William P Donnelly,
-
Vandana Sriram,
Chief Financial Officer -
Jeffrey Thomas Elliott,